SecBot SecBot
Insider Cluster (4 insiders) ·Filed May 15, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago
Insider cluster: 4 insiders, $1.0M total
Actionable Insight • Neutral

This insider cluster is routine and non-informative. The CEO and CFO are exercising options and selling a small fraction of the resulting shares, likely for tax or liquidity purposes. No bearish signal. Monitor the next 10-Q for any guidance revision or pipeline setback, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$564.82
T+0 close · May 15, 2026 · via day close
Latest settled
−9.88%
T+60 · $509.04
Vs SPY
−14.46%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 18 $564.82entry
  2. T+1 · 6mo ago −0.15%α +0.50% · $563.96
  3. T+5 · 6mo ago +1.85%α +0.23% · $575.25
  4. T+20 · 5mo ago −2.70%α −4.89% · $549.57
  5. T+60 · 3mo ago −9.88%α −14.46% · $509.04

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four UTHR insiders (CEO, CFO, EVP, Director) sold a total of ~$1.04M in open-market sales over a 7-day window following the Q1 2026 earnings release. The sales are small relative to the $24.4B market cap (~0.004%), and the CEO's and CFO's sales coincide with option exercises and tax-withholding transactions, suggesting routine portfolio management rather than a bearish signal. The cluster is not amplified by the earnings context because the sales are immaterial in size.

Key Financial Metrics

Direction
selling
Total Value
$1.0M
Insiders
4

Key Facts

  • Total open-market sales of ~$1.04M represent ~0.004% of UTHR's $24.4B market cap, well below the 0.1% materiality threshold.
  • CEO Rothblatt sold 1,378 shares ($793K) on May 13, but concurrently exercised 9,500 options at $146.03/share ($1.39M), indicating a net cash-neutral position adjustment.
  • CFO Edgemond sold 80 shares ($45K) on May 14 after exercising 10,000 options at $135.42/share ($1.35M) on May 11 and 14, the sales are trivial relative to the option exercises.
  • Director Mesa sold 258 shares ($150K), a routine diversification trade.
  • EVP Mahon sold 80 shares ($47K), de minimis.
  • The cluster follows Q1 2026 earnings (May 6) showing a 2% YoY revenue decline to $781.5M and a 15% net income decline to $274.9M, the insider sales are not reacting to new material information.
  • All sales are open-market (code S) and occur after option exercises (code M), consistent with tax-covering or cash-out patterns, not informed selling.

Financial Impact

Total insider sales of ~$1.04M are immaterial relative to $24.4B market cap, no financial impact.

Risk Factors

  • Q1 2026 revenue declined 2% YoY and net income fell 15%, the underlying business fundamentals are softening, but this insider cluster does not add incremental negative signal.
  • Tyvaso DPI growth (+9% YoY) is offset by Nebulized Tyvaso decline (-22%) and Remodulin decline (-8%), creating competitive uncertainty.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1778879076624

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (11h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026